C-SIAM: Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03069560
Collaborator
(none)
15
1
1
24.6
0.6

Study Details

Study Description

Brief Summary

Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Condition or Disease Intervention/Treatment Phase
  • Device: SMS
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts
Actual Study Start Date :
Jul 19, 2017
Actual Primary Completion Date :
Aug 8, 2019
Actual Study Completion Date :
Aug 8, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: SMS

The patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4.

Device: SMS
SMS contact from the caregiver with patient after discharge in intervention group

Outcome Measures

Primary Outcome Measures

  1. Measurement of the feasibility of the device by the patient according to a validated questionnaire [6 months]

    The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.

Secondary Outcome Measures

  1. The questionnaire measuring the feasibility for the caregiver of such a device [6 months]

    A questionnaire will be provided to the caregiver to measure the feasibility of such a device

  2. Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device [6 months]

    Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device

  3. Qualitative analysis of messages sent to patients during the study. [6 months]

    A qualitative analysis of the messages addressed to the patients during the study will be carried out.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female, over 18 years of age and hospitalized;

  • Survivor of a suicide attempt;

  • Giving informed, dated and signed consent;

  • Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.

Exclusion Criteria:
  • Patient whose clinical condition is incompatible with the formulation of his non-opposition.

  • The patient and his / her caregiver shall not be afforded a protective justice measure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Brest Brest France 29609

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03069560
Other Study ID Numbers:
  • C-SIAM (29.BRC.16.115)
First Posted:
Mar 3, 2017
Last Update Posted:
May 19, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2020